期刊名称：CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Clinical and Experimental Pharmacology and Physiology provides a medium for the rapid publication of original research papers, short communications, rapid communications and theoretical articles (hypotheses) on the results of clinical and experimental work in pharmacology and physiology. Invited review articles are published occasionally.
The Journal aims to make a substantial contribution to effective and productive communication between scientists throughout the world who are working in these interrelated disciplines. Clinical and Experimental Pharmacology and Physiology has been adopted by the High Blood Pressure Research Council of Australia (HBPRCA) and the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT).
Instructions to Authors
Manuscripts submitted for publication should be sent to:
CEPP Editorial Office
Department of Physiology
PO Box 13F
Monash University
Clayton Victoria 3800
Australia
Tel: +61 3 9589 2155
Fax: +61 3 9589 4355
e-mail: cepp@blackwellpublishingasia.com
Manuscripts may also be submitted to the Receiving Editors listed below:
Receiving Editor-Japan
Professor Yukio Yamori
WHO Collaborating Center for Research on Primary Prevention of Cardiovascular Diseases
86, Jodoji Shimobannba-cho
Sakyo-ku
Kyoto 606-8413
Japan
Email: cepp-yamori@kyoto.zaq.ne.jp
Receiving Editor-Europe
Professeur Jean Sassard
D閜artement de Physiologie et Pharmacologie Clinique
Facult?de Pharmacie
8 avenue Rockefeller
69373-Lyon Cedex 08
France
Fax +33 78 77 71 18
E-mail: sassard@cismsun.univ_lyon1fr
Receiving Editor-USA
Professor Gregory Fink
Department of Pharmacology and Toxicology
Michigan State University
East Lansing, Michigan 48824
Michigan
USA
Fax +1 517 353 8915
Email: finkg@pilot.msu.edu
Contributors should send three complete sets of the text (clearly typed and double-spaced), tables and figures, and should retain one set in case of damage or loss of papers in transit. The content of manuscripts will be held in strict confidence by the Editors and Referees.
Manuscript submission on disk
Contributors are requested to provide their manuscript in machine-readable form to speed up the editorial process. It is essential that, for each version of the manuscript, the hard copy and the file on the disk are identical. Contributors should use new/clean disks, rather than reformatted disks, and the disk should contain the relevant files only.
Contributors should supply their manuscript as formatted text on disk (any word-processing format can be handled). The manuscript should be divided into separate files for text and tables. It is essential that the hardware and the word processing package are specified on the disk, as well as the first author's surname, the journal title and the manuscript number.
Contributors are invited to submit manuscripts of Full Papers, Short Communications, Rapid Communications and Hypothesis papers. The content of Full Papers, Short Communications, Rapid Communications and Hypothesis papers may be in any of the fields that are covered by the title Clinical and Experimental Pharmacology and Physiology, interpreted in the broadest sense. The submission of a paper will imply the understanding that no substantial part of the content has been published or submitted for publication elsewhere, except as a brief abstract in the proceedings of a scientific meeting or symposium. Acceptance by Clinical and Experimental Pharmacology and Physiology will preclude the publication of the material content elsewhere except by permission of the Editors. Authors are asked to sign a Transfer of Copyright form on submission of their manuscript.
Contributions shall be written in the English language; spelling shall be as the standard dictionaries (e.g. The Shorter Oxford English Dictionary, Chambers Twentieth Century Dictionary); style should conform to that advocated in standard manuals of English usage. Contributors who are not fluent in English are advised to seek skilled advice on the composition of their papers. Style should conform to a standard manual such as Uniform Requirements for Manuscripts Submitted to Biomedical Journals, as presented in JAMA 1997, 277: 927-34. Papers should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. Minor amendments to manuscripts may be undertaken in the Editorial Office. The cost of extensive alterations in proof will be charged to the contributor and publication will be delayed.
The date of receipt of a manuscript by the Editorial Office will be published. It is anticipated that the time between receipt of a satisfactory manuscript of a Full Paper and its publication will be about 4 months, and for a Short Communication or Hypothesis the interval will be about 3 months. Rapid Communications will be published within 2 months.
Twenty-five offprints are supplied free. Additional copies may be ordered from the publisher when the proofs are returned.
The publication of abstracts or proceedings of affiliated societies and sets of papers from symposia may be undertaken, in ordinary issues or in special supplements, by arrangement with the editors and publishers.
Ethical matters
Investigations in human subjects must conform to the International Ethical Guidelines for Biomedical Research Involving Human Subjects (CIOMS/WHO). Consent must be obtained from each patient or subject after full explanation of the purpose, nature and risks of all procedures used, and the fact that such consent has been given should be recorded in the paper.
Experiments using animals must adhere to the highest acceptable standard of ethical practice. Currently, these are the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. The Code is obtainable from the Secretary, NHMRC, PO Box 9848, Canberra, ACT 2601 Australia. www.health.gov.au/nhmrc/research/awc/code.htm
The alternative is to use the CIOMS Guidelines.
The purpose of the experiments must have been to obtain significant scientific information relevant to humans or other animals. Authors must declare, either in a covering letter or in the paper itself, whether or not prior approval for experiments was obtained from an animal experimentation ethics committee, animal care and use committee, equivalent committee or relevant body in the country of question. The name of the committee or relevant body must be included.
Papers from countries where such committees are not established, or if such evidence is not provided, may be submitted to the relevant Australian Guidelines. Anaesthetic, analgesic or other measures taken to reduce or abolish any pain or discomfort must be detailed. If death or serious injury is used as an experimental end-point, the paper must indicate why such endpoints were essential. Neuromuscular blocking agents must not have been used without appropriate general anaesthesia, except in animals in which sensory awareness had been eliminated. Techniques and procedures which minimize the use of live animals must have been adopted where feasible and appropriate. The statistical methods should have ensured the use of the minimum number of animals compatible with valid experimentation.
Clinical and Experimental Pharmacology and Physiology retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies.
Full Papers
Title page
The first page of the manuscript should contain the following information: Title: The title should be as informative as possible and should indicate the species in which the observations reported have been made. Titles should not exceed 100 characters (including spaces).
Family name for each author, preceded by initial(s) or given name(s): That part of each family name which is to appear in indexes must be underlined.
Laboratory or Institute: The official name of each place in which the work reported in the manuscript was carried out should be given, together with the larger organization (if applicable), city, state (if applicable) and country.
Short title: This will be used as a running heading in the printed text; it must not exceed a total of 45 characters and spaces and should be as informative as possible within this limit.
Author for correspondence: The name and full postal address of the author to whom correspondence about the manuscripts, proofs and requests for reprints should be sent must be provided and clearly identified.
Present addresses of authors: Should the addresses of other authors differ from that of the author for correspondence, this information should be provided and will be published.
Summary
This should consist of a series of brief statements, arranged in numbered paragraphs, describing the aim of the study, what was done, the main findings and the conclusions reached. A limit of 350 words will normally apply.
Key words: These are required for indexing the content of the paper, and should, if possible, be selected from the current issue of 'Medical Subject Headings' produced by Index Medicus. A limit of 10 words or phrases should be sufficient. Key words should be arranged in alphabetical order.
Introduction
This should contain a concise statement of the reason for doing the work, and should not contain a major statement about either the findings or the conclusions.
Methods
Sufficient information should be given to permit the work to be repeated in other clinics or laboratories.
Results
The findings should be presented clearly with adequate reference to figures and tables. The text of Results and the information contained in figures and tables should complement one another; repetitive presentation of the same data should be avoided. Material appropriate to Discussion should not be included in Results; however brief comments on minor points are acceptable if they help to consolidate the new information being presented or if they assist the reader to follow the progression of ideas in moving from one set of data to another.
Discussion
This should not be a mere reiteration of the Results. It should deal with the relationship of the new information given in Results to the corpus of knowledge in that field, and should be pertinent to the data presented. The main conclusions should be incorporated in the final paragraph.
Acknowledgements
The source of financial support for the work reported in the paper must be acknowledged. Other acknowledgments should be kept as brief as courtesy and obligations allow.
References
Cite references in text by using superior Arabic numerals in the order in which they appear in the text. Abbreviate titles of the journals according to Index Medicus. References should be set out in the following way:
Standard journal article
1. Hoka S, Takeshita A, Yamamoto K, Ito N. Effects of high salt intake on control of hindlimb vascular resistance by arterial baroreflex and vagal afferents in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1993; 20: 663-9.
Books and other monographs
2. Dale MM, Forman JC, Fan TP. Textbook of Immunopharmacology, 3rd edn, Blackwell Science, Oxford. 1993.
Chapter in a book
3. Williams AJ. Potassium channel openers: Clinical aspects. In: Weston AH, Hamilton TC (eds). Potassium Channel Modulators. Blackwell Science, Oxford. 1992; Ch. 17.
Titles of papers and books are to be given in the original language of publication.
Figures and tables
These should be kept to the minimum necessary to convey essential data. References to tables and figures should be in Arabic numerals. Their desired location in relation to the body of the text should be indicated on the manuscript. The headings of tables and the legends or figures (listed on a separate page) should contain sufficient information to make them intelligible without reference to the text. Explanatory footnotes to a table should be indicated by symbols (*, +, +, ? and
Editorial Board
Editor朓n朇hief
Warwick P. Anderson
Department of Physiology, Monash University, Australia
Editor ?Pharmacology
Bevyn Jarrott
Department of Pharmacology, Monash University, Australia
Receiving Editor ?Japan
Yukio Yamori
WHO Collaborating Center on Research for Primary Prevention of Cardiovascular Diseases,
Kyoto, Japan
Receiving Editor ?Europe
Jean Sassard
D閜artement de Physiologie et Pharmacologie Clinique,
Facult?de Pharmacie, Lyon, France
Receiving Editor ?North America
Gregory Fink
Department of Pharmacology and Toxicology,
Michigan State University, East Lansing, Michigan, USA
Review Editor
John Ludbrook
c/- Editorial Office, CEPP, Department of Physiology,
Monash University, Australia
Editors?Advisory Council Clinical and Experimental Pharmacology and Physiology
James A. Angus
John Chalmers
John W. Funder
D. Ian McCloskey
Murray D. Esler
Stephen B. Harrap
Judith A. Whitworth
Colin I. Johnston
Scientific Society Editors
High Blood Pressure Research Council of Australia: S. Harrap, G. Head, L. Burrell
Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists: J. Ziogas
Australian Neuroscience Society: P. Martin
Australian Physiological and Pharmacological Society: I. McCance
Editorial Board
P.H. Barry Sydney
L.J. Beilin Perth
K.H. Berecek Birmingham, USA
M. Berndt Melbourne
C. Bianchi Pisa
J. Black Sydney
A. Bobik Melbourne
J. Burnett Rochester
V.M. Campese Los Angeles
B. Canny Melbourne
C.Y. Chai Taipei
C. Chen Melbourne
H.I. Chen Hualien
X. Chen Changsha
M.J. Cousins St Leonards
A.W. Cowley Milwaukee
J.A.J.H. Critchley Hong Kong
R. Day Sydney
G.F. DiBona Iowa City
G.J. Dusting Melbourne
J.-L. Elghozi Paris
M. Epstein Miami
R. Evans Melbourne
R. Fraser Glasgow
K. Fukiyama Okinawa
S. Gandevia Sydney
J.E. Hall Jackson
C. Han Beijing
K. Hattori Izumo, Japan
O. Iimura Sapporo
J.-L. Imbs Strasbourg
G. Jennings Melbourne
E.J. Johns Birmingham
G.A.R. Johnston Sydney
B.A.K. Khalid Kuala Lumpur
J.E. Krieger Sao Paulo
C.Y. Kwan Hamilton
C.P. Lau Hong Kong
L. Lisheng Beijing
E. Lumbers Sydney
E.M. McLachlan Randwick
Y. Masuyama Tokyo
F.A.O. Mendelsohn Melbourne
T.O. Morgan Melbourne
M.J. Mulvany Aarhus
P. Nambi Wilmington
S. Nosaka Tsu, Japan
T. Omae Osaka
P.A. Phillips Bedford Park
U. Proske Melbourne
S. Redman Canberra
A.M. Richards Christchurch
M. Safar Paris
T. Saruta Tokyo
A. Sato Ibaraki
J.B. Schnermann Ann Arbor
M. Stowasser Brisbane
D.朏. Su Shanghai
S. Sunano Osaka
T. Takeda Osaka
A. Takeshita Fukuoka
V. Tkachuk Moscow
C. Triggle Calgary
D.P. Westfall Reno
L. Wing Bedford Park
E.M. Wintour Melbourne
W.S.F. Wong Singapore
T.M. Wong Hong Kong
K. Yamamoto Osaka
T. Yao Shanghai
H.C.M. Yu Hong Kong
Editorial Office Administrator
Georgina Nunn
georgina.nunn@blackwellpublishingasia.com
Production Editor
Natalie Korszniak
natalie.korszniak@blackwellpublishingasia.com
| 
刊名字顺( Alphabetical List of Journals):
返回页首 